Skip to main content

Luveris FDA Approval History

FDA Approved: Yes (Discontinued) (First approved October 8, 2004)
Brand name: Luveris
Generic name: lutropin alfa
Dosage form: for Injection
Company: Serono, Inc.
Treatment for: Female Infertility

Marketing Status: Discontinued

Luveris (lutropin alfa) is a recombinant human form of luteinizing hormone indicated for use in combination with follitropin alfa for the stimulation of follicular development in infertile women.

Development timeline for Luveris

DateArticle
Oct  8, 2004Approval Luveris Serono, Inc. - Treatment for Infertility

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.